{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:46:36Z","timestamp":1793324796218,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T00:00:00Z","timestamp":1313193600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00417-011-1761-2","type":"journal-article","created":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T09:28:34Z","timestamp":1313141314000},"page":"1547-1552","source":"Crossref","is-referenced-by-count":15,"title":["Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens"],"prefix":"10.1007","volume":"249","author":[{"given":"Noriko","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Hisatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri-ichiro","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Imaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiko","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,13]]},"reference":[{"key":"1761_CR1","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480\u20131487","journal-title":"N Engl J Med"},{"key":"1761_CR2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0161-6420(98)92782-8","volume":"105","author":"RC Tripathi","year":"1998","unstructured":"Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP (1998) Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 105:232\u2013237","journal-title":"Ophthalmology"},{"key":"1761_CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0420.1997.tb00258.x","volume":"75","author":"J Fernandez-Vigo","year":"1997","unstructured":"Fernandez-Vigo J, Castro J, Macarro A (1997) Diabetic iris neovascularization. Natural history and treatment. Acta Ophthalmol Scand 75:89\u201393","journal-title":"Acta Ophthalmol Scand"},{"key":"1761_CR4","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2005.10.017","volume":"23","author":"HI Hurwitz","year":"2005","unstructured":"Hurwitz HI, Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, Holmgren E, Hambleton J, Novotny WF, Kabbinavar F (2005) Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol 23:3502\u20133508","journal-title":"J Clin Oncol"},{"key":"1761_CR5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3928\/1542-8877-20050701-15","volume":"36","author":"PJ Rosenfeld","year":"2005","unstructured":"Rosenfeld PJ, Fung AE, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36:336\u2013339","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"1761_CR6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","volume":"36","author":"PJ Rosenfeld","year":"2005","unstructured":"Rosenfeld PJ, Moshfeghi AA, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36:331\u2013335","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"1761_CR7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363\u2013372","journal-title":"Ophthalmology"},{"key":"1761_CR8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006982-200603000-00016","volume":"26","author":"RL Avery","year":"2006","unstructured":"Avery RL (2006) Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 26:352\u2013354","journal-title":"Retina"},{"key":"1761_CR9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00006982-200603000-00017","volume":"26","author":"FH Davidorf","year":"2006","unstructured":"Davidorf FH, Mouser JG, Derick RJ (2006) Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 26:354\u2013356","journal-title":"Retina"},{"key":"1761_CR10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajo.2006.02.015","volume":"142","author":"Y Oshima","year":"2006","unstructured":"Oshima Y, Sakaguchi H, Gomi F, Tano Y (2006) Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol 142:155\u2013158","journal-title":"Am J Ophthalmol"},{"key":"1761_CR11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ajo.2006.06.066","volume":"142","author":"ME Iliev","year":"2006","unstructured":"Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM (2006) Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 142:1054\u20131056","journal-title":"Am J Ophthalmol"},{"key":"1761_CR12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1600-0420.2006.00731.x","volume":"84","author":"PJ Silva","year":"2006","unstructured":"Silva PJ, Jorge R, Alves CR, Rodrigues ML, Scott IU (2006) Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scan 84:556\u2013557","journal-title":"Acta Ophthalmol Scan"},{"key":"1761_CR13","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.ophtha.2008.02.026","volume":"115","author":"T Wakabayashi","year":"2008","unstructured":"Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, Otori Y, Kamei M, Kusaka S, Tano Y (2008) Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 115:1571\u20131580","journal-title":"Ophthalmology"},{"key":"1761_CR14","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/bjo.80.8.750","volume":"80","author":"T Kubota","year":"1996","unstructured":"Kubota T, Tawara A, Hata Y, Khalil A, Inomata H (1996) Neovascular tissue in the intertrabecular spaces in eyes with neovascular glaucoma. Br J Ophthalmol 80:750\u2013754","journal-title":"Br J Ophthalmol"},{"key":"1761_CR15","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","volume":"246","author":"DW Leung","year":"1989","unstructured":"Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306\u20131309","journal-title":"Science"},{"key":"1761_CR16","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","volume":"1","author":"T Alon","year":"1995","unstructured":"Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024\u20131028","journal-title":"Nat Med"},{"key":"1761_CR17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0008-6363(00)00268-6","volume":"49","author":"I Zachary","year":"2001","unstructured":"Zachary I, Gliki G (2001) Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49:568\u2013581","journal-title":"Cardiovasc Res"},{"key":"1761_CR18","first-page":"1029","volume":"146","author":"HF Dvorak","year":"1995","unstructured":"Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029\u20131039","journal-title":"Am J Pathol"},{"key":"1761_CR19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajo.2010.03.016","volume":"150","author":"R Kohno","year":"2010","unstructured":"Kohno R, Hata Y, Mochizuki Y, Arita R, Kawahara S, Kita T, Miyazaki M, Hisatomi T, Ikeda Y, Aiello LP, Ishibashi T (2010) Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection. Am J Ophthalmol 150:223\u2013229","journal-title":"Am J Ophthalmol"},{"key":"1761_CR20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bjo.2008.148148","volume":"93","author":"T Kubota","year":"2009","unstructured":"Kubota T, Aoki R, Harada Y, Tou N, Kohno Y, Tawara A, Satoh H, Shimajiri S (2009) Trabecular meshwork in neovascular glaucoma eyes after the intravitreal injection of bevacizumab. Br J Ophthalmol 93:557\u2013558","journal-title":"Br J Ophthalmol"},{"key":"1761_CR21","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M009705200","volume":"276","author":"I Kim","year":"2001","unstructured":"Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276:7614\u20137620","journal-title":"J Biol Chem"},{"key":"1761_CR22","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1172\/JCI17712","volume":"112","author":"ME Reinders","year":"2003","unstructured":"Reinders ME, Sho M, Izawa A, Wang P, Mukhopadhyay D, Koss KE, Geehan CS, Luster AD, Sayegh MH, Briscoe DM (2003) Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 112:1655\u20131665","journal-title":"J Clin Invest"},{"key":"1761_CR23","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/bjo.2006.108795","volume":"91","author":"SK Gibran","year":"2007","unstructured":"Gibran SK, Sachdev A, Stappler T, Newsome R, Wong D, Hiscott P (2007) Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin). Br J Ophthalmol 91:602\u2013604","journal-title":"Br J Ophthalmol"},{"key":"1761_CR24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1755-3768.2008.01439.x","volume":"88","author":"N Lassota","year":"2010","unstructured":"Lassota N, Prause JU, Scherfig E, Kiilgaard JF, la Cour M (2010) Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization. Acta Ophthalmol 88:300\u2013308","journal-title":"Acta Ophthalmol"},{"key":"1761_CR25","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00417-010-1406-x","volume":"248","author":"Y Sugimoto","year":"2010","unstructured":"Sugimoto Y, Mochizuki H, Okumichi H, Takumida M, Takamatsu M, Kawamata S, Kiuchi Y (2010) Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients. Graefes Arch Clin Exp Ophthalmol 248:1601\u20131609","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1761_CR26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1755-3768.2009.01648.x","volume":"88","author":"Y Saito","year":"2010","unstructured":"Saito Y, Higashide T, Takeda H, Ohkubo S, Sugiyama K (2010) Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma. Acta Ophthalmol 88:96\u2013102","journal-title":"Acta Ophthalmol"},{"key":"1761_CR27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/IJG.0b013e3181d9ce12","volume":"20","author":"Y Takihara","year":"2011","unstructured":"Takihara Y, Inatani M, Kawaji T, Fukushima M, Iwao K, Iwao M, Tanihara H (2011) Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma. J Glaucoma 20:196\u2013201","journal-title":"J Glaucoma"},{"key":"1761_CR28","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1136\/bjo.2008.141317","volume":"92","author":"S Julien","year":"2008","unstructured":"Julien S, Heiduschka P, Hofmeister S, Schraermeyer U (2008) Immunohistochemical localisation of intravitreally injected bevacizumab at the posterior pole of the primate eye: implication for the treatment of retinal vein occlusion. Br J Ophthalmol 92:1424\u20131428","journal-title":"Br J Ophthalmol"},{"key":"1761_CR29","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1167\/iovs.06-1171","volume":"48","author":"P Heiduschka","year":"2007","unstructured":"Heiduschka P, Fietz H, Hofmeister S, Schultheiss S, Mack AF, Peters S, Ziemssen F, Niggemann B, Julien S, Bartz-Schmidt KU, Schraermeyer U, T\u00fcbingen Bevacizumab Study Group (2007) Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci 48:2814\u20132823","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1761-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-011-1761-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1761-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T01:04:43Z","timestamp":1560474283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-011-1761-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,13]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1761"],"URL":"https:\/\/doi.org\/10.1007\/s00417-011-1761-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,13]]}}}